Literature DB >> 16337169

Identification of a spurious band on serum protein electrophoresis induced by ethanol treatment.

Yusheng Zhu1, Ronald J Elin.   

Abstract

BACKGROUND: Treatment of serum with ethanol at 100 ml/l eliminating fibrinogen from electrophoretic pattern produces an additional band at alpha2/beta junction. This study is to determine the source and the nature of this artifact.
METHODS: The supernatant after ethanol precipitation was used for electrophoresis. Protein concentrations of each fraction in ethanol- and saline-treated samples were compared, and immunofixation electrophoresis (IFE) to identify transferrin, C3, and LDL was performed. C3 IFE was also conducted for fresh sera and sera stored for 2 weeks.
RESULTS: The artificial band at alpha2/beta junction was identified in ethanol-treated sera but not in saline-treated sera. Protein concentration in the beta fraction was reduced after ethanol treatment as compared to saline-treated samples (n=10, p<0.01). The spurious band at alpha2/beta junction was recognized in C3 IFE. C3 IFE also showed a band at alpha2/beta junction in samples stored for 2 weeks.
CONCLUSIONS: Ethanol treatment of serum creates an artificial band with C3 immunoreactivity at alpha2/beta junction. This could be due to the accelerated hydrolysis of C3 by ethanol treatment. Laboratories using ethanol to evaluate a possible fibrinogen band should be aware of this phenomenon, and the serum protein electrophoretic pattern after ethanol treatment should only be used to rule out fibrinogen.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16337169     DOI: 10.1016/j.cca.2005.09.030

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  1 in total

1.  γ/IgG ratio: role in distinguishing monoclonal spikes from fibrinogen.

Authors:  Maria Teresa Lee; Patrizio Caturegli; Richard L Humphrey; Richard E Thompson; Barbara Detrick
Journal:  J Clin Lab Anal       Date:  2011       Impact factor: 2.352

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.